Successful use of C1 inhibitor during mitral valve replacement surgery with cardiopulmonary bypass

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 2, 2008, Pages 220-

  Codispote, Chris D ^a   Rezvani, Maziar ^a   Bernstein, Jonathan A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ANNULOPLASTY; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; DRUG USE; HUMAN; LABORATORY TEST; LETTER; MAINTENANCE THERAPY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; SUBSTITUTION THERAPY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 49449085881     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60214-1     Document Type: Letter

References (4)

1. Bernstein JA, ed. Hereditary angioedema: a current state-of-the-art review. Ann Allergy Asthma Immunol. 2008;100(suppl):S1-S48.
2. Jaffe CJ, Atkinson JP, Gelfand JA, Frank MM. Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol. 1975;55:386-393.
3. Alvarez JM. Successful use of C1 esterase inhibitor protein in a patient with hereditary angioneurotic edema requiring coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2000;119:168-171.
4. Segal H, Sheikh S, Kallis P, et al. Complement activation during major surgery: the effect of extracorporeal circuits and high-dose aprotinin. J Cardiothorac Vasc Anesth. 1998;12:542-547.